Enovis (NYSE:ENOV) Share Price Breaks Below 50 Day Moving Average – Here’s What Happened

Enovis Corporation (NYSE:ENOV) shares passed below its 50-day moving average during trading on Friday. The stock has a 50-day moving average of $20.02 and traded as low as $19.83. Enovis shares last traded at $19.92, with a volume of 2,524,526 shares traded.

Wall Street Analysts Forecast Growth

A number of research firms recently issued reports on ENOV. Evercore set a $32.00 price target on shares of Enovis in a research note on Monday, July 6th. BTIG Research dropped their price objective on shares of Enovis from $40.00 to $36.00 and set a “buy” rating for the company in a research note on Tuesday, September 1st. Canaccord Genuity Group dropped their price objective on shares of Enovis from $50.00 to $45.00 and set a “buy” rating for the company in a research note on Monday, August 17th. Zacks Research upgraded shares of Enovis from a “strong sell” rating to a “hold” rating in a report on Wednesday, July 29th. Finally, UBS Group restated a “buy” rating and set a $44.00 target price on shares of Enovis in a research report on Monday, October 5th. Ten analysts have rated the stock with a Buy rating, one has assigned a Hold rating and one has given a Sell rating to the company’s stock. Based on data from MarketBeat, the company currently has an average rating of “Moderate Buy” and a consensus price target of $37.25.

Enovis Price Performance

The company has a current ratio of 1.98, a quick ratio of 1.00 and a debt-to-equity ratio of 0.84. The company has a market capitalization of $1.15 billion, a PE ratio of -1.03 and a beta of 1.37. The stock’s 50-day moving average is $20.02 and its two-hundred day moving average is $23.08.

Enovis (NYSE:ENOV) last announced its quarterly earnings data on Thursday, August 6th. The company reported $0.90 earnings per share (EPS) for the quarter, topping the consensus estimate of $0.85 by $0.05. Enovis had a negative net margin of 47.96% and a positive return on equity of 12.03%. The business had revenue of $582.78 million during the quarter, compared to the consensus estimate of $581.84 million. During the same quarter last year, the firm earned $0.79 earnings per share. The firm’s quarterly revenue was up 3.2% compared to the same quarter last year. Enovis has set its FY 2026 guidance at 3.520-3.730 EPS. On average, equities analysts predict that Enovis Corporation will post 3.15 EPS for the current year.

Insider Activity at Enovis

In other Enovis news, CEO Damien Mcdonald purchased 13,035 shares of Enovis stock in a transaction dated Friday, September 4th. The shares were purchased at an average cost of $19.15 per share, for a total transaction of $249,620.25. Following the completion of the acquisition, the chief executive officer owned 247,077 shares in the company, valued at $4,731,524.55. This represents a 5.57% increase in their position. The acquisition was disclosed in a legal filing with the SEC, which is available at this hyperlink. Also, insider Oliver Engert purchased 2,660 shares of the firm’s stock in a transaction that occurred on Friday, September 4th. The shares were acquired at an average cost of $18.80 per share, with a total value of $50,008.00. Following the completion of the purchase, the insider directly owned 63,898 shares in the company, valued at $1,201,282.40. The trade was a 4.34% increase in their position. Additional details regarding this purchase are available in the official SEC disclosure. Over the last quarter, insiders bought 23,293 shares of company stock worth $449,599. Company insiders own 2.90% of the company’s stock.

Institutional Trading of Enovis

A number of hedge funds and other institutional investors have recently bought and sold shares of the business. MGO One Seven LLC bought a new stake in shares of Enovis during the third quarter worth $200,000. State of Wyoming boosted its stake in shares of Enovis by 49.1% during the third quarter. State of Wyoming now owns 17,354 shares of the company’s stock valued at $317,000 after purchasing an additional 5,713 shares during the period. Inspire Investing LLC grew its holdings in shares of Enovis by 4.9% in the third quarter. Inspire Investing LLC now owns 34,833 shares of the company’s stock worth $636,000 after purchasing an additional 1,631 shares during the last quarter. SBI Securities Co. Ltd. bought a new position in shares of Enovis in the third quarter worth about $55,000. Finally, Integrated Wealth Concepts LLC bought a new position in shares of Enovis in the second quarter worth about $39,000. Hedge funds and other institutional investors own 98.45% of the company’s stock.

About Enovis

Enovis Corporation (NYSE: ENOV) is a medical technology company that develops, manufactures and distributes products designed to improve patient recovery, mobility and quality of life. Its portfolio serves orthopedic, sports medicine, physical therapy and rehabilitation markets, as well as other areas of musculoskeletal care.

The company’s products include orthopedic implants and surgical technologies, braces and supports, cold and compression therapy systems, electrotherapy and rehabilitation equipment, and other solutions used by hospitals, surgeons, physical therapists, athletic trainers and patients.